Rockville-based Rise Therapeutics develops oral immunotherapies that use synthetic biology to target dendritic cells and recalibrate immune responses in autoimmune disease and cancer. The clinical-stage company pairs its proprietary oral delivery platform with in-house clinical GMP manufacturing, taking candidates from discovery through human clinical validation. Its pipeline includes oral programs for ulcerative colitis, rheumatoid arthritis, and cancer.
Good Manufacturing Practice (GMP)
Compliance program
Good Clinical Practice (GCP)
Compliance program
21 CFR Part 11
Compliance program
ISO-5 Cleanroom Infrastructure
Compliance program
ISO-7 Supporting Areas
Compliance program
GMP
Quality certification